Role of insulin-like growth factor-1 (IGF-1) in regulating cell cycle progression

Biochemical and Biophysical Research Communications

Volumn 389, Issue 1, 2009, Pages 150-155

  Ma, Qi lin ^a   Yang, Tian lun ^a   Yin, Ji ye ^b   Peng, Zhen yu ^a   Yu, Min ^b   Liu, Zhao qian ^b   Chen, Fang ping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

Author keywords

Angiotensin II; Apoptosis; Cell cycle; Insulin like growth factor 1; Signaling pathway

Indexed keywords

ANGIOTENSIN II; CYCLIN E; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SOMATOMEDIN C;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; ENDOTHELIUM CELL; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; CELL CYCLE; CYCLIN E; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, MESSENGER;

EID: 70349134683     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.08.114     Document Type: Article

References (21)

1. Kook H., Itoh H., Choi B.S., Sawada N., Doi K., Hwang T.J., Kim K.K., Arai H., Baik Y.H., and Nakao K. Physiological concentration of atrial natriuretic peptide induces endothelial regeneration in vitro. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H1388-H1397
2. Strawn W.B., and Ferrario C.M. Mechanisms linking angiotensin II and atherogenesis. Curr. Opin. Lipidol. 13 (2002) 505-512
3. Dimmeler S., and Zeiher A.M. Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors. Regul. Pept. 90 (2000) 19-25
4. Leri A., Liu Y., Wang X., Kajstura J., Malhotra A., Meggs L.G., and Anversa P. Overexpression of insulin-like growth factor-1 attenuates the myocyte renin-angiotensin system in transgenic mice. Circ. Res. 84 (1999) 752-762
5. Osterziel K.J., Bode-Boger S.M., Strohm O., Ellmer A.E., Bit-Avragim N., Hanlein D., Ranke M.B., Dietz R., and Boger R.H. Role of nitric oxide in the vasodilator effect of recombinant human growth hormone in patients with dilated cardiomyopathy. Cardiovasc. Res. 45 (2000) 447-453
6. Dzau V.J. Theodore Cooper Lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 37 (2001) 1047-1052
7. de Gasparo M. Angiotensin II and nitric oxide interaction. Heart Fail. Rev. 7 (2002) 347-358
8. Dimmeler S., Rippmann V., Weiland U., Haendeler J., and Zeiher A.M. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ. Res. 81 (1997) 970-976
9. Nakashima H., Suzuki H., Ohtsu H., Chao J.Y., Utsunomiya H., Frank G.D., and Eguchi S. Angiotensin II regulates vascular and endothelial dysfunction: recent topics of Angiotensin II type-1 receptor signaling in the vasculature. Curr. Vasc. Pharmacol. 4 (2006) 67-78
10. Desideri G., Bravi M.C., Tucci M., Croce G., Marinucci M.C., Santucci A., Alesse E., and Ferri C. Angiotensin II inhibits endothelial cell motility through an AT1-dependent oxidant-sensitive decrement of nitric oxide availability. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1218-1223
11. Nickenig G., and Harrison D.G. The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis. Circulation 105 (2002) 393-396
12. Okura Y., Brink M., Zahid A.A., Anwar A., and Delafontaine P. Decreased expression of insulin-like growth factor-1 and apoptosis of vascular smooth muscle cells in human atherosclerotic plaque. J. Mol. Cell. Cardiol. 33 (2001) 1777-1789
13. Juul A., Scheike T., Davidsen M., Gyllenborg J., and Jorgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 106 (2002) 939-944
14. Jia G., Cheng G., and Agrawal D.K. Differential effects of insulin-like growth factor-1 and atheroma-associated cytokines on cell proliferation and apoptosis in plaque smooth muscle cells of symptomatic and asymptomatic patients with carotid stenosis. Immunol. Cell Biol. 84 (2006) 422-429
15. Saetrum Opgaard O., and Wang P.H. IGF-I is a matter of heart. Growth Horm. IGF Res. 15 (2005) 89-94
16. Kaplan R.C., Strickler H.D., Rohan T.E., Muzumdar R., and Brown D.L. Insulin-like growth factors and coronary heart disease. Cardiol. Rev. 13 (2005) 35-39
17. Michell B.J., Griffiths J.E., Mitchelhill K.I., Rodriguez-Crespo I., Tiganis T., Bozinovski S., de Montellano P.R., Kemp B.E., and Pearson R.B. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr. Biol. 9 (1999) 845-848
18. Schini-Kerth V.B. Dual effects of insulin-like growth factor-I on the constitutive and inducible nitric oxide (NO) synthase-dependent formation of NO in vascular cells. J. Endocrinol. Invest. 22 (1999) 82-88
19. Cooke J.P., and Losordo D.W. Nitric oxide and angiogenesis. Circulation 105 (2002) 2133-2135
20. Hoffmann J., Haendeler J., Aicher A., Rossig L., Vasa M., Zeiher A.M., and Dimmeler S. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ. Res. 89 (2001) 709-715
21. Ichiki T., Usui M., Kato M., Funakoshi Y., Ito K., Egashira K., and Takeshita A. Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension 31 (1998) 342-348